Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
12:00 AM - DEVICE TALKS
9
11
12
13
14
16
18
19
20
21
22
23
24
26
27
28
29
30
31
1
2
3
4
DEVICE TALKS
DEVICE TALKS BOSTON 2018: BIGGER AND BETTER THAN EVER! Join us Oct. 8-10 for the 7th annual DeviceTalks Boston, back in the city where it [...]
6th Annual HealthIMPACT Midwest
2018-10-10    
All Day
REV1 VENTURES COLUMBUS, OH The Provider-Patient Experience Summit - Disrupting Delivery without Disrupting Care HealthIMPACT Midwest is focused on technologies impacting clinician satisfaction and performance. [...]
15 Oct
2018-10-15 - 2018-10-16    
All Day
Conference Series Ltd invites all the participants from all over the world to attend “3rd International Conference on Environmental Health” during October 15-16, 2018 in Warsaw, Poland which includes prompt keynote [...]
17 Oct
2018-10-17 - 2018-10-19    
7:00 am - 6:00 pm
BALANCING TECHNOLOGY AND THE HUMAN ELEMENT In an era when digital technologies enable individuals to track health statistics such as daily activity and vital signs, [...]
Epigenetics Congress 2018
2018-10-25 - 2018-10-26    
All Day
Conference: 5th World Congress on Epigenetics and Chromosome Date: October 25-26, 2018 Place: Istanbul, Turkey Email: epigeneticscongress@gmail.com About Conference: Epigenetics congress 2018 invites all the [...]
Events on 2018-10-08
DEVICE TALKS
8 Oct 18
425 Summer Street
Events on 2018-10-10
Events on 2018-10-17
17 Oct
Events on 2018-10-25
Epigenetics Congress 2018
25 Oct 18
Istanbul
Latest News

Emerson Electric Co. (NYSE: EMR) – worth at $111?

Emerson Electric Co. (NYSE: EMR) is under scrutiny today. Its stock has surged by 24% in recent months on the NYSE, nearing its 52-week peak. This indicates that any shifts in the company’s prospects may already be reflected in its stock price. Yet, is there still room for a good deal? Let’s delve into Emerson Electric’s valuation and future outlook to gauge potential bargain opportunities.

Assessing Emerson Electric’s Value
Our valuation model suggests the stock is currently reasonably priced, sitting approximately 8.2% below its intrinsic value. If you subscribe to the belief that the company’s true value stands at $121.19, there might not be much upside beyond its current price. However, the stock’s high beta suggests that in bearish markets, its price could drop more steeply than the broader market, presenting a favorable entry point.

Prospects for Growth
Looking ahead, future growth prospects are crucial, especially for investors seeking portfolio expansion. Investing in a strong company at a discounted rate is usually wise. Emerson Electric anticipates a robust 45% profit growth in the coming years, indicating potential for increased cash flow and higher stock valuation.

Implications for Investors
For current shareholders, it appears that EMR’s positive outlook is already factored into its fair value. However, other factors like the company’s financial stability warrant consideration. For potential investors, while now might not be the optimal time to buy given the fair valuation, the promising outlook suggests delving deeper into factors such as the strength of the company’s balance sheet to capitalize on future price fluctuations.